Capricor Inc.
Clinical trials sponsored by Capricor Inc., explained in plain language.
-
New hope for duchenne: major trial tests cell therapy to preserve muscle function
Disease control OngoingThis study is testing whether a cell therapy called deramiocel can slow the loss of muscle function in boys and young men with Duchenne muscular dystrophy (DMD). About 106 participants will receive either the therapy or a placebo via IV infusion every three months for a year, wit…
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Hope for duchenne: Five-Year cell therapy trial aims to slow progression
Disease control OngoingThis study is a long-term follow-up for patients who completed a previous trial for Duchenne muscular dystrophy. It aims to provide continued access to an experimental cell therapy called deramiocel and gather more data on its long-term safety and whether it helps slow the loss o…
Phase: PHASE2 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC